EPiC drugs have the potential to efficiently and effectively cross the blood-brain barrier (BBB) to treat a wide range of brain diseases and brain-related disorders, many of which represent unmet medical needs including brain cancers, pain management, diabetes, obesity and neurological disorders such as Parkinson???s disease.